Evolocumab halves cardiovascular events in exploratory analysis
Further lowering LDL reduces risk in post-ACS patients
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy